终末期肝病患者在急诊科表现为感染性休克的临床特征与结局
该回顾性研究纳入2014年1月至2016年5月急诊成人感染性休克路径登记的全部患者,比较终末期肝病(ESLD)与非ESLD患者的临床特征与结局,并分析ESLD幸存者与非幸存者的差异。共纳入2584例感染性休克患者,ESLD占6.2%(n=161)。ESLD患者死亡率36.6%,显著高于非ESLD患者的21.2%(p<0.001)。ESLD患者更年轻、女性更多、肥胖更多、合并症更多,体温更低、乳酸更高、急性肾损伤发生率更高;两组抗生素使用和液体复苏无差异,ESLD患者接受更多急诊血管升压药支持。在ESLD感染性休克患者中,最高乳酸和肺炎作为感染源与死亡独立相关。
要点
- 急诊感染性休克患者中ESLD占6.2%(n=161),其死亡率36.6% vs 非ESLD 21.2%(p<0.001)。
- ESLD感染性休克患者更年轻、女性、肥胖、合并症多,体温更低、乳酸更高、急性肾损伤更多。
- 两组抗生素使用和液体复苏无差异,但ESLD患者接受更多急诊血管升压药支持。
- 在ESLD感染性休克患者中,最高乳酸和肺炎作为感染源与死亡独立相关,可用于早期识别高危患者。
适用人群与场景
- 2014年1月至2016年5月在本中心急诊成人感染性休克路径登记的感染性休克患者。
- 比较终末期肝病(ESLD)患者与非ESLD患者;另在ESLD患者中比较幸存者与非幸存者。
研究设计与关键结果
- 回顾性研究,纳入2584例急诊感染性休克患者,ESLD占6.2%(n=161)。
- ESLD患者死亡率36.6% vs 非ESLD患者21.2%(p<0.001)。
- ESLD患者更年轻、女性更多、肥胖更多、其他合并症更多;体温更低、乳酸更高、急性肾损伤发生率更高。
- 两组抗生素使用和液体复苏无差异;ESLD患者接受更多急诊血管升压药支持。
- 在ESLD感染性休克患者中,最高乳酸和肺炎作为感染源与死亡独立相关。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对急诊感染性休克中的ESLD患者应认识到其死亡率显著高于非ESLD患者(36.6% vs 21.2%)。
- ESLD感染性休克患者中,最高乳酸和肺炎作为感染源与死亡独立相关,作者认为可用于早期识别高危ESLD脓毒症患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with end stage liver disease (ESLD) are particularly vulnerable to sepsis. ESLD patients are often excluded from controlled sepsis trials and more data are needed to guide the management of this population.
OBJECTIVE: To describe the clinical factors and outcomes of patients with ESLD presenting to the emergency department (ED) with septic shock.
METHODS: We performed a retrospective review of patients registered in our dedicated ED adult septic shock pathway. All patients registered between January 2014 and May 2016 were included. Clinical and treatment variables for ESLD patients were compared with non-ESLD patients. A second analysis assessed ESLD survivors compared to non-survivors.
RESULTS: 2,584 septic shock patients were enrolled. ESLD was present in 6.2% (n = 161) of patients. Patients with ESLD had higher mortality compared to patients without ESLD 36.6% vs 21.2% (p < 0.001). ESLD patients were more likely to be younger, female, obese, and have other comorbidities. ESLD patients exhibited lower temperature, higher lactate, and higher incidence of acute kidney injury. There was no difference in antibiotics or fluid resuscitation between groups. ESLD patients received more ED vasopressor support. Among ESLD septic shock patients, maximum lactate and presence of pneumonia were independently associated with death.
CONCLUSIONS: Patients with ESLD comprise a small but important subgroup of patients with ED septic shock that experience high mortality compared to patients without ESLD. Maximum ED lactate and pneumonia as the source of sepsis are independently associated with adverse outcome and may be used for early recognition of high-risk ESLD sepsis patients.
参考来源
- Okonkwo E, Rozario N, Heffner AC, et al. Presentation and outcomes of end stage liver disease patients presenting with septic shock to the emergency department. Am J Emerg Med. 2019. PMID: 31839522. doi:10.1016/j.ajem.2019.11.039
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。